Free Newsletter

  Email address:
   

Site Search

Bayer Finally Closes Topsun Acquisition

publication date: Jul 3, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Bayer HealthCare announced that its China subsidiary has finally received regulatory approval to complete its acquisition of Topsun's OTC cough and cold portfolio. The takeover has been under way for a long time: it was originally announced in October 2006, and ChinaBio® Today reported five months ago that the deal received a last-minute reprieve only after a technical breach of its drop-dead date. More details...

Stock Symbols: (XE: 575200) (SHA: 600771)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio Events

October 24, 2008
Beijing, China

>> More details...

Partner Events
 
October 11-13, 2008
Dalian, China
 
November 08, 2008
The Institute of Americas, UCSDa
 
November 9-11, 2008
Shanghai, China
 
February 23-25, 2009
San Diego

>> More details...

Partners